Hill-Rom installs patient monitoring into smart bed
January 8, 2018
Indiana-based hospital bed maker Hill-Rom has integrated continuous contact-free heart rate and respiratory rate sensing and analytics technology into its Centrella Smart+ bed.
The technology comes from Israeli company EarlySense, a specialist in contact-free continuous monitoring across the care continuum.
The Centrella bed, which offers patient safety and caregiver-focused technology, now allows for continuous monitoring of patients' heart and respiratory rates over 100 times per minute without touching the patient. EarlySense technology alerts clinicians to potential patient deterioration events much earlier than traditional monitoring methods, enabling health teams to intervene and avoid failure-to-rescue scenarios more effectively.
"Hill-Rom's Centrella bed is transforming inpatient care by integrating advanced sensing and analytics into the bed, offering a complete patient safety platform to assist clinicians in providing the highest level of care," said John Groetelaars, president and CEO of Hill-Rom. "EarlySense has been used to effectively monitor close to a million patients, positively affecting patient outcomes. By integrating the EarlySense technology into our Centrella beds, we are ushering in a new era in quality of care, whereby all patients can be continuously monitored throughout their entire hospital stay."
Specific improved clinical outcomes demonstrated with this technology include helping reduce mortality related to code blue events by 83 per cent and cardiac arrests by 86 per cent. In addition, clinicians reported overall hospital length-of-stay was reduced by nine per cent and ICU days by 45 per cent. Several EarlySense customers have reported that the system also assisted with early detection of sepsis, a condition that, when not identified and treated rapidly, may be life threatening.
"No patient should deteriorate without prior warning in the hospital environment," said Frank Overdyk, a South Carolina-based anaesthesiologist and expert on respiratory compromise. “Continuous vital signs measurement should be the standard of clinical practice in the USA. Events such as opioid-induced respiratory depression and loss of life from failure-to-rescue are no longer acceptable given the availability of continuous vital signs monitoring."
Hill-Rom is a medical technology company with more than 10,000 employees worldwide. It partners health care providers in more than 100 countries, across all care settings, by focusing on patient care in five core areas –mobility, wound care and prevention, patient monitoring and diagnostics, surgical safety and efficiency, and respiratory health.
"We are proud to be Hill-Rom's exclusive bed integration and nurse call communications partner, making our sensing and analytics technology available for more hospital patients and ensuring timely, effective clinical intervention is achieved," said Avner Halperin, co-founder and CEO of EarlySense. "Integrating EarlySense monitoring capabilities with the Hill-Rom Centrella bed platform will advance our collective aspiration of having every patient in every hospital continuously monitored for safe, data-driven care, with the potential to save thousands of lives and significant costs for the healthcare system."
Used worldwide in hospitals, post-acute care facilities and homes, EarlySense assists clinicians in early detection of patient deterioration. It has been proven to help prevent adverse events, including code blue events that are a result of cardiac or respiratory arrest, preventable ICU transfers, patient falls, pressure ulcers and hospital readmissions. The FDA-cleared products leverage artificial intelligence and big data analytics to provide actionable health insights and improve clinical outcomes.